Write a 4-5 page paper describing use of a specific screening tool.
Write a 4-5 page paper describing use of a specific screening tool.
Your writing Assignment should:
follow the conventions of Standard English (correct grammar, punctuation, etc.);
be well ordered, logical, and unified, as well as original and insightful;
be a minimum of 4 pages in length, not including cover or reference page;
display superior content, organization, style, and mechanics; and;
use APA formatting and citation style
Discuss what diagnosis you are using the tool for, how to score the tool and support use of the tool with evidence and rationale. Next develop a treatment plan for the patient based on your findings in the diagnostic test and interpretation.
Sections should include:
Introduction to diagnostic tool
Discussion of Tool: why it is used, how, and for what diagnosis
Discussion of Interpretation of Scoring for the Tool
Treatment Plan for patients with positive results from the tool, include, non-pharmacological and pharmacological approaches, patient education, additional testing required, and follow-up as needed.
Conclusion
All references must be scholarly and include Doi numbers.
Proper English grammar and spelling is required.
The DSM – 5 must be used as a reference.
Write a 4-5 page paper describing use of a specific screening tool.
Your writing Assignment should:
follow the conventions of Standard English (correct grammar, punctuation, etc.);
be well ordered, logical, and unified, as well as original and insightful;
be a minimum of 4 pages in length, not including cover or reference page;
display superior content, organization, style, and mechanics; and;
use APA formatting and citation style
Discuss what diagnosis you are using the tool for, how to score the tool and support use of the tool with evidence and rationale. Next develop a treatment plan for the patient based on your findings in the diagnostic test and interpretation.
Sections should include:
Introduction to diagnostic tool
Discussion of Tool: why it is used, how, and for what diagnosis
Discussion of Interpretation of Scoring for the Tool
Treatment Plan for patients with positive results from the tool, include, non-pharmacological and pharmacological approaches, patient education, additional testing required, and follow-up as needed.
Conclusion
All references must be scholarly and include Doi numbers.
Proper English grammar and spelling is required.
The DSM – 5 must be used as a reference.
Answer & Explanation
Solved by verified expert
Introduction to the diagnostic tool (the SBIRT screening tool).
The SBIRT screening test is a diagnostic instrument that is used to screen for substance use disorders and assess their severity. The test includes of a series of questions concerning a person’s alcohol and other drug usage, as well as a family history of substance use disorders. The assessment is intended for physicians to utilize in order to develop a more accurate diagnosis of a person’s substance use problem.
Use of the SBIRT sreening tool.
Clinicians utilize the SBIRT screening tool to check for and assess the severity of substance use problems. The test includes of a series of questions concerning a person’s alcohol and other drug usage, as well as a family history of substance use disorders. The assessment is intended for physicians to utilize in order to develop a more accurate diagnosis of a person’s substance use problem.
Interpretation of Scoring for the Tool.
The total number of points scored on the questions about alcohol and drug use is subtracted from the total number of points scored on the questions about family history of substance use disorders to get the tool’s score. The following is how the final score is interpreted:
0-7 scores = no problem with drugs or alcohol.
8-15 points equals a mild substance abuse problem.
16-23 points equals a moderate substance abuse problem.
A score of 24 or higher indicates a severe substance abuse problem.
Patient’s treatment plan based on the tool’s positive results.
It is suggested that someone who scores positive on the SBIRT screening instrument seek treatment for their substance use disorder. Counseling, 12-step programs, and medication-assisted treatment are all possible treatment choices.
Non-pharmacological and pharmacological approaches.
Counseling, 12-step programs, and behavioral therapies are examples of non-pharmacological ways to treating substance use disorders. Pharmacological approaches to treating substance use disorders include medication-assisted treatment, which employs pharmaceuticals to help reduce cravings and withdrawal symptoms.
Patient education.
Patients who test positive for SBIRT should be informed about the seriousness of their substance use disorder and the need of getting treatment. Patients should also be informed about the many treatment options available, as well as the associated risks and advantages.
Additional testing is necessary.
If a person scores positive on the SBIRT screening instrument, more testing is needed to confirm the diagnosis of a drug use problem. A physical examination, laboratory testing, and psychological assessment are all options for testing.
Appointments for follow-up.
If a person’s SBIRT screening results are positive, they should see a physician for further evaluation and therapy. Counseling, medication management, and participation in a 12-step program may all be part of the follow-up appointments.
Step-by-step explanation
Srinivasan, S., Payne, R., & Laiwala, R. (2016). Overage drinking: Alcohol use disorders in older adults and role of SBIRT as evidence-based approach to diagnosis and management. The American Journal of Geriatric Psychiatry, 24(3), S5-S6.
Shogren, M. D., Harsell, C., & Heitkamp, T. (2017). Screening women for at‐risk alcohol use: an introduction to screening, brief intervention, and referral to treatment (SBIRT) in women’s health. Journal of Midwifery & Women’s Health, 62(6), 746-754.
Thompson, A. C., Thompson, M. O., Young, D. L., Lin, R. C., Sanislo, S. R., Moshfeghi, D. M., & Singh, K. (2015). Barriers to follow-up and strategies to improve adherence to appointments for care of chronic eye diseases. Investigative ophthalmology & visual science, 56(8), 4324-4331.
Tarter, R. E., & Hegedus, A. M. (1991). The Drug Use Screening Inventory: Its applications in the evaluation and treatment of alcohol and other drug abuse. Alcohol Research and Health, 15(1), 65.
